MetaCap

Viatris Inc. (VTRS)

NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.63-0.25 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VTRS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$22.50B
EPS (TTM)
-$0.53
Dividend yield
2.45% ($0.48)
Ex-dividend date
Nov 23, 2026
52-week range
10.39 – 21.20
Day range
19.43 – 20.10
Volume / Avg
9.27M / 9.11M
Beta
—

52-week range

$10.39$21.20

VTRS stock today

Shares of Viatris (VTRS) finished lower on Nov 20 at $19.63, a drop of 1.26% or $0.25 per share, versus the S&P 500's 3.70% decline. Shares are 7.4% below their 52-week high of $21.20, set on Nov 12, 2026 and 88.9% above the 52-week low of $10.39, near the top of the past year's range. VTRS is up 57.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 87.7%.

Viatris has posted a net loss over the last twelve months (EPS of -$0.53), so its P/E ratio is not meaningful. To receive the next $0.12 dividend, investors must own shares before the Nov 23 ex-dividend date.

Summary generated from market data by MetaCap's automated system. Methodology

About Viatris

Company profile

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Scott Andrew Smith Ph.D.
Headquarters
Canonsburg, PA
Employees
30,000

Financial highlights

Full financials

In fiscal 2025, Viatris generated $14.30 billion in revenue, down 3.0% from fiscal 2024, its first annual decline since 2024. Viatris reported a net loss of $3.51 billion, compared with a loss of $634.2 million a year earlier. Gross margin was 35.1% (down from 38.2%) and operating margin -18.6%.

Viatris annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$14.30B$14.74B$15.43B$16.26B$17.89B
Growth-2.98%-4.46%-5.14%-9.08%+49.73%
Net income$-3.51B$-634.20M$54.70M$2.08B$-1.27B
EPS (diluted)$-3.00$-0.53$0.05$1.71$-1.05

Analyst forecast

Forecast

Consensus (12 analysts)

buy

Avg. price target

$21.60+10.04%

  • Strong buy 1
  • Buy 6
  • Hold 4
  • Sell 0
  • Strong sell 1

Target range

Low $14.00High $28.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$-0.28 vs $0.64
Surprise
-143.75%

Dividends

Dividend history
Annual dividend
$0.48
Last payment
$0.12
Ex-dividend date
Nov 23, 2026
Pay date
Dec 16, 2026

VTRS news

All VTRS news

Viatris peers

Health Care sector
VTRS peer companies
CompanyPrice% ChgMarket capCompare
UTHRUnited Therapeutics Corporation554.73-0.78%$23.63Bvs VTRS
ALNYAlnylam Pharmaceuticals Inc.143.82-2.71%$19.26Bvs VTRS
ROIVRoivant Sciences Ltd.38.66-0.78%$28.01Bvs VTRS
ASNDAscendis Pharma A/S252.73-1.26%$16.58Bvs VTRS
BBIOBridgeBio Pharma Inc.76.03-2.75%$14.81Bvs VTRS
JAZZJazz Pharmaceuticals plc230.26-2.62%$14.78Bvs VTRS
INSMInsmed Incorporated141.33-2.17%$31.01Bvs VTRS
GMABGenmab A/S ADS50.60-1.46%$31.20Bvs VTRS

Indexes, lists and sector

Viatris stock FAQ

What is Viatris's stock price today?

VTRS last traded at $19.63 as of Nov 20, 4:00 PM EST, down 1.26% on the day. Prices are delayed at least 15 minutes.

Does Viatris pay a dividend?

Yes. Viatris pays $0.48 per share annually, a 2.45% yield. The most recent dividend of $0.12 had an ex-dividend date of Nov 23, 2026.

Is Viatris in the S&P 500?

Yes. Viatris (VTRS) is a constituent of the S&P 500 index.

Who is Viatris's CEO?

Mr. Scott Andrew Smith Ph.D. is the chief executive officer of Viatris Inc., which has about 30,000 employees.

Has VTRS ever split its stock?

Yes. The most recent VTRS stock split was a 3-for-2 split on Oct 9, 2003, one of 4 splits on record.

What is the VTRS 52-week high?

The 52-week high for VTRS is $21.20 and the 52-week low is $10.39. The stock is currently 7.4% below its high.

Compare VTRS